MSB 3.21% $1.13 mesoblast limited

Ann: Mesoblast Phase 3 Chronic Heart Failure Results, page-354

  1. 4,680 Posts.
    lightbulb Created with Sketch. 718
    Johnson & Johnson announce product candidate reduces death by cardiac issues by 60% KABBBOOOMMM
    Eli Lilly announce product candidate reduces death by cardiac issues by 60% VOOOOOOMMMMM
    Pfizer announce product candidate reduces death by cardiac issues by 60% WWWOOOOOOOOWWWWWW
    Merck announce product candidate reduces death by cardiac issues by 60% JJJAAAWWWWWDDRRROOPPPIIINNNGGGG

    Mesoblast actually DO announce product candidate reduces death by cardiac issues by 60% - ASX and cronies, dddaaahhhh, is this good? What's FinReview say.....I don't know.......


    no-wonder the black box flew overseas......
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.